New data on congressional stock purchases highlights multiple positions that posted exceptional gains after their public disclosure. These returns are measured from the DISCLOSURE date forward and the public could have seen each of these positions when they were filed. Four House members across party lines entered trades in the one thousand to fifteen thousand dollar range that later produced substantial performance visible to any investor reviewing the filings on senate.gov or related government portals.
Positions flagged as needs_review are treated as outliers we are still verifying rather than asserting specific performance figures. Rep. Lisa McClain bought SNDK with disclosure on November 21 2025. Rep. Ro Khanna purchased WDC and MRNA both disclosed January 6 2026. Each of these stands as an outlier we are still verifying.
Corroborated filings show clear outperformance. Rep. Lisa McClain's CIEN buy disclosed August 13 2025 has returned 422.65 percent since disclosure. Rep. Tim Moore purchased TZA disclosed on July 9 2025 delivering a 327.72 percent return from the filing date. Rep. Rob Bresnahan bought GLW disclosed May 8 2025 for a 276.52 percent gain since it became public. These span technology and healthcare sectors plus an inverse small-cap ETF with days held ranging from 474 to 648.
The overlap in technology names and the scale of post-disclosure gains add to patterns our analysis has tracked in recent months though this cohort stands out for its verified magnitude among buys rather than sales. While transaction dates precede disclosure by weeks or months the data underscores what was available to retail investors the moment each filing hit the public record. As congressional trading volume remains elevated these examples provide a transparent lens for tracking how disclosed positions have performed in live markets without any implication of non-public information.
This is data analysis, not financial advice.
This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.